Sangeetha Venugopal is a board-certified hematologist who trained at renowned institutions, including Montefiore Medical Center and the Icahn School of Medicine at Mount Sinai in New York, and completed an additional leukemia focused fellowship at the UT MD Anderson Cancer Center in Houston, Texas. A well-published clinician-investigator, Dr. Venugopal focuses research on improving treatment outcomes for patients with myeloid malignancies such as myelodysplastic syndromes (MDS) through clinical trials, translational investigations, and precision medicine approaches.